A. Killeen

D. Nickerson, K. Beckman, C. McLaren, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evaluation of an Ion-Exchange HPLC Device for HbA1c Measurement.

J. Peters, A. Killeen, A. Saenger, 2020, The journal of applied laboratory medicine.

Accuracy of Three Commercial Home-Use HbA1c Tests.

R. Beck, J. Lum, C. Kollman, 2022, Diabetes technology & therapeutics.

Diagnosis of classical steroid 21-hydroxylase deficiency using an HLA-B locus-specific DNA-probe.

H. Orr, A. Killeen, R. Ulstrom, 1988, American journal of medical genetics.

Analysis of vitamin levels and deficiencies in bariatric surgery patients: a single-institutional analysis.

S. Ikramuddin, A. Killeen, D. Leslie, 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Extended major histocompatibility complex haplotypes in celiac patients in the west of Ireland.

A. Mannion, A. Killeen, F. Stevens, 1993, American journal of medical genetics.

Molecular and endocrine characterization of a mutation involving a recombination between the steroid 21-hydroxylase functional gene and pseudogene

H. Orr, A. Killeen, K. Sane, 1991, The Journal of Steroid Biochemistry and Molecular Biology.

Genotyping of apolipoprotein e.

A. Killeen, I. C. Ozturk, N. Akel, 2001, Methods in molecular medicine.

Chromosomal aneuploidy in leukemic blast crisis: a potential source of error in interpretation of bone marrow engraftment analysis by VNTR amplification.

A. Killeen, S. Sheldon, N. Akel, 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.

J. D. de Lemos, D. Kitzman, C. Ballantyne, 2022, Journal of the American College of Cardiology.

Quantitative analysis in molecular diagnostics.

A. Killeen, R. Mcglennen, R. Staggs, 1994, Human pathology.

Prevalence of nonclassical congenital adrenal hyperplasia among women self-referred for electrolytic treatment of hirsutism.

A. Killeen, J. Eckfeldt, R. Eklund, 1992, American journal of medical genetics.

Kidney Function Specific Reference Limits for N-terminal Pro Brain Natriuretic Peptide and High Sensitivity Troponin T: The Systolic Blood Pressure Intervention Trial

N. Bansal, J. D. de Lemos, M. Shlipak, 2022, Kidney Medicine.

Integrating Molecular Testing into Clinical Applications

A. Killeen, 2010, Biomarkers in Drug Discovery and Development.

Linked linear amplification for simultaneous analysis of the two most common hemochromatosis mutations.

A. Killeen, C. Hixson, L. Ugozzoli, 2003, Clinical chemistry.

THE ROAD TO A PARKINSON ’ S DISEASE BIOMARKER

A. Killeen, 2020 .

Molecular Diagnoses of Human Immunodeficiency Virus and Hepatitis C Virus

A. Killeen, 2004 .

Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.

A. Schmaier, A. Killeen, D. Normolle, 2000, American journal of clinical pathology.

Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategies

A. Killeen, W. Mcdonnell, Y. Hitomi, 1995, Journal of viral hepatitis.

Certification in molecular pathology in the United States (Training and Education Committee, The Association for Molecular Pathology).

A. Killeen, V. V. Van Deerlin, K. Snow, 2002, Journal of Molecular Diagnostics.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

Walter T Ambrosius, Anthony A Killeen, Jackson T. Wright, 2014, Clinical trials.

Molecular pathology protocols

A. Killeen, 2000 .

Protein Self-Organization Patterns in Dried Serum Reveal Changes in B-Cell Disorders

A. Sarvazyan, A. Killeen, N. Ossina, 2012, Molecular Diagnosis & Therapy.

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, Diabetes Care.

Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults

J. Hodges, L. Sokoll, A. Killeen, 2017, JAMA.

Basic Concepts in Molecular Pathology

A. Killeen, 2004 .

Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis system.

Eric B. Roesch, C. Richmond, J. Grenier, 2003, Clinical chemistry.

Extraction of Nucleic Acids

A. Killeen, P. Bogner, 2006 .

Familial Cancer Syndromes

A. Killeen, 2004 .

An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.

A. Killeen, C. Keegan, 2001, The Journal of molecular diagnostics : JMD.

Molecular Pathology of Hematological Malignancies

A. Killeen, 2004 .

Molecular Analysis of Congenital Adrenal Hyperplasia in a Newborn Screening Program

A. Killeen, 2001, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

BRCA1 mutation testing: controversies and challenges.

E. Petty, A. Killeen, 1997, Clinical chemistry.

Genome-Wide Association Study Identifies Genetic Loci Associated with Iron Deficiency

D. Nickerson, K. Beckman, B. Snively, 2009, PloS one.

Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.

P. Joshi, W. Ambrosius, S. Blankenberg, 2021, JAMA cardiology.

Analysis of CYP21 coding polymorphisms in three ethnic populations: further evidence of nonamplifying CYP21 alleles among whites.

M. Rubenfire, L. Palaniappan, A. Killeen, 2000 .

Characterization of frequent polymorphisms in intron 2 of CYP21: application to analysis of segregation of CYP21 alleles.

A. Killeen, R. Jiddou, K. Sane, 1998, Clinical chemistry.

Molecular Origins of Cancer

A. Killeen, 2004 .

Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.

A. Killeen, G. Myers, L. Thienpont, 2005, Archives of pathology & laboratory medicine.

Tumor Lysis Syndrome.

A. Killeen, Shelly M. Williams, 2018, Archives of pathology & laboratory medicine.

State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry.

Lothar Siekmann, W Greg Miller, Gary L Myers, 2008, Archives of pathology & laboratory medicine.

Total long-term within-laboratory precision of cortisol, ferritin, thyroxine, free thyroxine, and thyroid-stimulating hormone assays based on a College of American Pathologists fresh frozen serum study: do available methods meet medical needs for precision?

A. Killeen, D. Palmer-Toy, G. Klee, 2005, Archives of pathology & laboratory medicine.

College of American Pathologists 2003 fresh frozen serum proficiency testing studies.

A. Killeen, G. Klee, 2005, Archives of pathology & laboratory medicine.

Laboratory sanctions for proficiency testing sample referral and result communication: a review of actions from 1993-2006.

A. Killeen, 2009, Archives of Pathology & Laboratory Medicine.

Cardiovascular risk factors in ethnic minority women aged < or =30 years.

M. Rubenfire, L. Palaniappan, A. Killeen, 2002, The American journal of cardiology.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

A. Cheung, W. Ambrosius, T. Craven, 2019, European heart journal.

Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants

A. Cheung, B. Freedman, M. Shlipak, 2020, American Journal of Nephrology.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

P. Whelton, M. Rocco, Mahboob Rahman, 2017, Annals of internal medicine.

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

J. Williamson, S. Oparil, P. Kimmel, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

A. Cheung, W. Ambrosius, T. Craven, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney tubule health, mineral metabolism, and adverse events in persons with CKD in SPRINT.

A. Cheung, W. Ambrosius, J. D. de Lemos, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

D. Reboussin, F. Elahi, L. Launer, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT

W. Ambrosius, J. D. de Lemos, R. Toto, 2022, Circulation.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

S. Oparil, A. Cheung, W. Ambrosius, 2018, Clinical journal of the American Society of Nephrology : CJASN.

An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HBALC.

R. Beck, J. Lum, C. Kollman, 2021, Diabetes technology & therapeutics.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as a rapid screening method to detect mutations causing Tay-Sachs disease.

A. Killeen, D. Lubman, P. Venta, 1997, Rapid Communications in Mass Spectrometry.

Osmotic Demyelination Syndrome after Correction of Hyponatremia: A Case Report.

A. Killeen, A. Olson, Vikram Palamalai, 2018, The journal of applied laboratory medicine.

Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.

J. Williamson, S. Oparil, G. Chelune, 2020, Journal of the American Society of Nephrology : JASN.

Serum Sodium and Pulse Pressure in SPRINT.

W. Ambrosius, J. Kostis, S. Glasser, 2019, American journal of hypertension.

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT

W. Ambrosius, J. D. de Lemos, C. Ballantyne, 2022, Journal of the American Heart Association.

Recent trends in performance and current state of creatinine assays.

Christina B. Ventura, A. Killeen, E. Ashwood, 2013, Archives of pathology & laboratory medicine.

Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor.

A. Killeen, K. Meyer, J. R. Edson, 1987, American Journal of Clinical Pathology.

Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.

A. Killeen, L. Bowers, 1987, Obstetrics and gynecology.

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions

M. Rocco, C. Lewis, J. Cutler, 2016, American Journal of Nephrology.

Methods in Molecular Pathology

A. Killeen, 2004 .

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

K. Sink, S. Oparil, T. Craven, 2014, Journal of the American Society of Hypertension : JASH.

Quality management for molecular genetic testing: Clinical and Laboratory Standards Institute (CLSI) MM20-P

E. Dequeker, A. Killeen, Jianli Dong, 2012 .

Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).

P. Whelton, M. Rocco, S. Oparil, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

Michael S. Reidy, Tanya M. Teslovich, Anne W. Ndungu, 2023, Diabetologia.

Quantification of nucleic acids.

A. Killeen, 1997, Clinics in Laboratory Medicine.

Verifying performance characteristics of quantitative analytical systems: calibration verification, linearity, and analytical measurement range.

Tom Long, George G Klee, Anthony A Killeen, 2014, Archives of pathology & laboratory medicine.

Effects of Intensive BP Control in CKD.

P. Whelton, K. Sink, M. Rocco, 2017, Journal of the American Society of Nephrology : JASN.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)

J. Williamson, P. Whelton, Joni K. Snyder, 2014, Clinical trials.

Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.

A. Killeen, G. Myers, L. Thienpont, 2005, Archives of pathology & laboratory medicine.

Genotyping of apolipoprotein E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

A. Killeen, D. Lubman, M. Kachman, 1998, Rapid communications in mass spectrometry : RCM.